Novartis India Ltd
Stage 2 · Advancing · week 27Setup 4.8 WatchEven +0.6
As of 16 Oct 2026, Novartis India is in Stage 2 — advancing, the uptrend phase, in week 27 (since 8 Apr 2026). It closed at ₹1,898, 21.9% below its 52-week high and above its 200-day average, which is rising. In Health Care, 40.6% of stocks are in Stage 2.
₹1,897.6
-2.19% today
₹4,685 Cr · Small cap
Pro read
ProOur read
In Stage 2, but it has already run
Setup score
4.8 Watch
Momentum
Steady
Edge
Even +0.6
Setup-score rank among Stage 2 peers: #26 of 60 in Pharmaceuticals · #33 of 71 in Health Care
Is NOVARTIND early, or has it already run? Pro answers that for every NSE stock, after every close.
vs 52W High
-21.9%
₹759.3 lo₹2,428.2 hi
21.9% below 52W high — deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 27
1w13w26w
Week 27 — mature, watch for distribution
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
45.8%
200 DMA: ₹1,301.4 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.27x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
→
MA20 flat · -0.2% vs MA50 +9.0%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-4.9%
3M
+20.9%
6M
+90.6%
YTD
+141.0%
1Y
+117.8%
Sector
Health Care
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
This stock ranks #8 of 67 Stage 2 stocks in Health Care by RS. Leading the sector.
Industry
Pharmaceuticals
Stage 2%
50.4%
20d Δ
-2.5pp
1M return
-2.3%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Ranks #8 of 57 Stage 2 stocks in this industry. Top tier.
Moving averages & range
50 DMA
₹1,811.5
200 DMA
₹1,301.4
52W High
₹2,428.2
52W Low
₹759.3
5D Low
₹1,897.6
Resistance levels (recent highs)
20d High
₹2,051.2
60d High
₹2,428.2
120d High
₹2,428.2
250d High
₹2,428.2
Next resistance
+8.1%
to 20d High
All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.